Some patients with end-stage heart failure and atrial fibrillation appear to respond significantly and positively to combination catheter ablation and guideline-directed medical therapy. Investigators reported their findings on… read more.
Researchers from a newly published study report that, among patients with atrial fibrillation, the risk of developing dementia among those who underwent catheter ablation was about half that… read more.
Boston Scientific Corporation announced it has received FDA approval for the POLARx Cryoablation System.The new system, which is indicated for the treatment of patients with paroxysmal atrial fibrillation… read more.
– Primary results of the FROZEN-AF IDE trial with the POLARx Cryoablation System : Results from the global, prospective, non-randomized, single-arm FROZEN-AF IDE study of the POLARx Cryoablation… read more.
Statin therapy appears to reduce the risk of stroke or transient ischemic attack in patients with atrial fibrillation, and longer use gives more protection. The findings were presented… read more.
Morbid obesity at age 18 may be linked to an elevated risk of atrial fibrillation in younger middle age, according to a study of around 1.7 million men… read more.
Among patients diagnosed with atrial fibrillation (AF) and valvular heart disease (VHD), those treated with apixaban have achieved a lower rate of ischemic stroke or systemic embolism and… read more.
A large retrospective study of patients diagnosed with atrial fibrillation (AF) and valvular heart disease (VHD) showed that apixaban treatment was associated with a lower rate of ischemic… read more.
Extended cardiac monitoring in patients and the use of implantable cardiovascular electronic devices can increase detection of atrial fibrillation (AF), but the devices have limitations including short battery… read more.
Atrial fibrillation (AF) is a major risk factor for stroke, and for decades the anticoagulant warfarin was the standard treatment for lowering that hazard. However, numerous drug and… read more.
A six-month exercise programme helps maintain normal heart rhythm and reduces the severity of symptoms in patients with atrial fibrillation, according to a study by researchers at the University… read more.
Abbott has announced that the FDA approved the company’s Amplatzer Amulet Left Atrial Appendage Occluder to treat people with atrial fibrillation (AFib) who are at risk of ischemic… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
